Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zynerba Pharmaceuticals, Inc. - Common Stock (NQ:ZYNE)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Zynerba Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Psychedelic Stocks Finally In An Upswing
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index went up +5.3% last week. 
Via Talk Markets
Cannabis Stock Gainers And Losers From January 31, 2022
GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76 
Via Benzinga
The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses. 
Via Talk Markets
Cannabis Stock Gainers And Losers From January 28, 2022
GAINERS: BioHarvest Sciences (OTC:CNVCF) shares closed up 19.61% at $0.33 
Via Benzinga
Cannabis Stock Gainers And Losers From January 26, 2022
GAINERS: Item 9 Labs (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 24, 2022
GAINERS: Leviathan Natural Prods (OTC: 
Via Benzinga
Weekend Update: Only 2 Psychedelic Drug Stocks Are Up YTD
This article updates the performances of the 16 largest capitalized clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses out of a... 
Via Talk Markets
Cannabis Stock Gainers And Losers From January 18, 2022
GAINERS: Item 9 Labs (OTC: 
Via Benzinga
Marijuana & Psychedelic Drug Stocks Continue To Decline
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 16 of the 100 such companies that trade on North American stock exchanges. 5 of them are marijuana drug stocks and 11 are... 
Via Talk Markets
Cannabis Stock Gainers And Losers From January 14, 2022
GAINERS: Cannabix Technologies (OTC: 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to... 
Via Benzinga
Cannabis Stock Gainers And Losers From January 13, 2022
GAINERS: MGC Pharmaceuticals (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 12, 2022
GAINERS: Cannabix Technologies (OTC: 
Via Benzinga
Pure-Play Marijuana- & Psychedelic Compounds-Based Drug Stocks Index Is Down By 66% From 2021 High
There are 16 remaining constituents of our Marijuana & Psychedelic Compounds-Based Drug Stocks Index is now DOWN -65.9% from its highs in 2021. Here are the details for each of its constituents. 
Via Talk Markets
Cannabis Stock Gainers And Losers From January 5, 2022
GAINERS: Rhinomed (OTC: 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this... 
Via Benzinga
Is Medical Marijuana Really A Slippery Slope? CVSI Distribution Agreement with GNC
The Best Daily Overview Of The Cannabis Space CV Sciences Announces New Distribution Agreement with GNC. $CVSI ... 
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,... 
Via Benzinga
Zynerba Discontinues Development Of Cannabidiol Gel In Epileptic Disorders
Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) has decided not to advance Zygel against developmental and epileptic encephalopathies (DEE). The decision was in line... 
Via Benzinga
Cannabis Stock Gainers And Losers From January 3, 2022
GAINERS: BioHarvest Sciences (OTC: 
Via Benzinga
Marijuana & Psychedelic Compounds-Based Drug Stocks Now Down -16% YTD
A look at which index has done the best so far in December: the Marijuana Drug Stocks Index or the Psychedelic Compounds-Based Drug Stocks Index. 
Via Talk Markets
Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November
A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance. 
Via Talk Markets
Topics Cannabis
$UBER Jumps into Canadian Cannabis; NASDAQ Issues MCTO to $CRON — Cannabis Daily November 22, 2021
The Best Daily Overview Of The Cannabis Space Uber enters into cannabis space in Ontario, Canada by listing Tokyo Smoke in its ma... 
Via Benzinga
Topics Cannabis
The Biotech Stock Numbers You Need to Know
Biotech investing is different from other kinds of investing because biotech is pretty much the only sector in which companies go public before they have a product to sell. Let's take a look at Zynerba... 
Via Talk Markets
September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances
Which index out-performed in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index? 
Via Talk Markets
Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September
Which index has outperformed so far in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index? 
Via Talk Markets
Topics Cannabis
Zynerba Stock Moves Higher On Long-Term Zygel Data In Autistic Children
Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) presented data from the Phase 2 BRIGHT trial of Zygel in children and adolescents with autism spectrum disorder (ASD) over a... 
Via Benzinga
Marijuana Vs. Psychedelic Drug Stocks: Which Out-Performed Last Week?
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 8 constituents in each of two sub-categories, let's see which out-performed last week. 
Via Talk Markets
Topics Cannabis
Marijuana Drug Stocks: All You Need To Know Is Here!
Eight clinical-stage companies researching the treatment of a wide variety of illnesses using marijuana of which 6 have market capitalizations in excess of $50M and less than $500M and 2 have market... 
Via Talk Markets
Topics Cannabis
Which Psychedelic Drug Stock Category Outperformed Last Week
Which has performed best YTD, the Pure-Play Marijuana Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index? 
Via Talk Markets
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.